ConductScience.org, home

Paper32223935

TRK inhibitors in TRK fusion-positive cancers.

Drilon A. Ann Oncol, 2019. Cited by 122 papers, by iCite.

Cite this record

ConductScience Library. TRK inhibitors in TRK fusion-positive cancers. Papers, record 32223935. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32223935

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
TRK inhibitors in TRK fusion-positive cancers.
PubMed
Journal
Ann Oncol
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
122
iCite
Relative citation ratio, by iCite
4.28
iCite
Revised in PubMed
2020-11-16
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Drilon AA

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
NeoplasmsMajor topic
Oncogene Proteins, FusionMajor topic
Protein Kinase InhibitorsMajor topic
Receptor, trkAMajor topic
Animals
Clinical Trials as Topic
Humans
Molecular Targeted Therapy

Source PubMed

Download CSV of topics

Cited by49

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 122 citations.

PMIDTitleJournalYearIn PapersSource
42539561TRK immunohistochemistry in pediatric rhabdomyosarcomas: diagnostic and prognostic utility and limitations.Pathol Oncol Res2026https://conductscience.org/library/papers/42539561PubMed
42151502Targeting fusion proteins in solid tumors: from oncogenic mechanisms to clinical interventions.Acta Pharmacol Sin2026https://conductscience.org/library/papers/42151502PubMed
41502888Successful treatment of pediatric scalp mesenchymal tumor with NTRK rearrangement: a case report.Transl Pediatr2025https://conductscience.org/library/papers/41502888PubMed
41301083Niclosamide and Palbociclib Act Synergistically to Reduce Cholangiocarcinoma Cell Viability In Vitro and Inhibit Tumour Growth in a Mouse Model.Cancers (Basel)2025https://conductscience.org/library/papers/41301083PubMed
40990633Molecular advances in early-stage and locally advanced non-small cell lung carcinoma: Shaping the future of precision oncology-systematic review.Sci Prog2025https://conductscience.org/library/papers/40990633PubMed
40666929Development of PROTACs for targeted degradation of oncogenic TRK fusions.bioRxiv2025https://conductscience.org/library/papers/40666929PubMed
40385986RNA hybrid-capture next-generation sequencing has high sensitivity in identifying known and less characterized oncogenic and likely oncogenic NTRK fusions in a real-world standard-of-care setting.Front Genet2025https://conductscience.org/library/papers/40385986PubMed
39639242NTRK fusion promotes tumor migration and invasion through epithelial-mesenchymal transition and closely interacts with ECM1 and NOVA1.BMC Cancer2024https://conductscience.org/library/papers/39639242PubMed
39366294Evolving therapeutic landscape of advanced biliary tract cancer: from chemotherapy to molecular targets.ESMO Open2024https://conductscience.org/library/papers/39366294PubMed
39326005A pilocytic astrocytoma with novel ATG16L1::NTRK2 fusion responsive to larotrectinib: a case report with genomic and functional analysis.Oncologist2025https://conductscience.org/library/papers/39326005PubMed
39014476NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitors.Acta Neuropathol Commun2024https://conductscience.org/library/papers/39014476PubMed
38938274Basket Trials: Past, Present, and Future.Annu Rev Cancer Biol2024https://conductscience.org/library/papers/38938274PubMed
38791513Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells.Int J Mol Sci2024https://conductscience.org/library/papers/38791513PubMed
38662171SEOM-GEINO clinical guidelines for grade 2 gliomas (2023).Clin Transl Oncol2024https://conductscience.org/library/papers/38662171PubMed
38359439Advances in targeted therapy of cholangiocarcinoma.Ann Med2024https://conductscience.org/library/papers/38359439PubMed
38329731Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland.Oncotarget2024https://conductscience.org/library/papers/38329731PubMed
38322338Selective type II TRK inhibitors overcome xDFG mutation mediated acquired resistance to the second-generation inhibitors selitrectinib and repotrectinib.Acta Pharm Sin B2024https://conductscience.org/library/papers/38322338PubMed
37900189The 5th Edition of the World Health Organization Classification of Tumours of the Eye and Orbit.Ocul Oncol Pathol2023https://conductscience.org/library/papers/37900189PubMed
37707537INTEGRATE-Circ and INTEGRATE-Vis: unbiased detection and visualization of fusion-derived circular RNA.Bioinformatics2023https://conductscience.org/library/papers/37707537PubMed
37385995Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37385995PubMed

See all 49 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
NTRK14914PubTator's text mininghttps://conductscience.org/library/genes/4914NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32223935

GET https://conductscience.org/api/papers/v1/32223935/cited_by?page=2